Villosin C is primarily investigated for its potential antitumor and anticancer properties. It has shown inhibitory effects against certain cancer cell lines by interfering with cell proliferation and inducing apoptosis. Research suggests it may act through modulation of signaling pathways involved in cell survival and death, making it a candidate for development in oncology therapeutics. Additionally, Villosin C exhibits anti-inflammatory activity, which could contribute to its overall therapeutic effect in cancer and other diseases involving chronic inflammation. Its application remains largely in the preclinical research stage, focusing on understanding its mechanism and optimizing its biological activity.